Business
Currency:USD
2024/FY
Stock NameRevenueRatio
BioPharma62.4B98.07%
Other business activities1.23B1.93%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States38.69B60.81%
Developed Markets16.06B25.24%
Emerging Markets6.33B9.95%
China2.55B4.00%